Next Generation News and Research

RSS

Cedars-Sinai Graduate Program to award diplomas to six students

The Cedars-Sinai Graduate Program in Biomedical Sciences and Translational Medicine will award its first diplomas to six students during a commencement ceremony June 11.

11 Jun 2013

Summa Akron City Hospital installs Toshiba's Aquilion ONE, Infinix-i systems

As a level-one trauma and accredited stroke center, time is critical at Summa Health System's Akron City Hospital, located in Akron, Ohio. To provide the highest level of patient care, the hospital installed an Aquilion ONE CT scanner and Infinix-i bi-plane cardiovascular X-ray from Toshiba America Medical Systems, Inc.

10 Jun 2013

Data emphasise need for comprehensive analysis of mtDNA in mitochondrial disease patients

French scientists have discovered that supposedly rare mutations in the mitochondria, the 'power plants' of human cells responsible for creating energy, account for more than 7% of patients with a mitochondrial disease manifesting itself as a respiratory deficiency.

10 Jun 2013

McGill researchers use computer simulations to show how immune cells identify foreign antigens

How do immune cells manage to sort through vast numbers of similar-looking proteins within the body to detect foreign invaders and fight infections?

10 Jun 2013

Researchers find new way to repair genetic defects in the skin cells of epidermolysis bullosa patients

A research team led by pediatric blood and marrow transplantation experts Mark Osborn, Ph.D. and Jakub Tolar, M.D., Ph.D. from the Masonic Cancer Center, University of Minnesota, have discovered a remarkable new way to repair genetic defects in the skin cells of patients with the skin disease epidermolysis bullosa.

10 Jun 2013

CytomX collaborates with Pfizer to develop, commercialize more effective antibody-drug conjugates

CytomX Therapeutics, Inc., a biotechnology company developing a new generation of targeted antibody therapeutics, today announced that it has entered into a global strategic collaboration with Pfizer Inc. to develop and commercialize multiple Probody-Drug Conjugates.

6 Jun 2013

WHO issues 24 Essential Nutrition Actions to prevent undernutrition and overweight

Many low- and middle-income countries are neglecting overweight and obesity as major health threats, with policies in place to tackle undernutrition, but lack policies to halt the growing burden of diseases due to the rise of overweight, and obesity, according to new information released by WHO today.

6 Jun 2013

PROLOR Biotech announces initiation of hGH-CTP Phase III trial in growth hormone deficient adults

PROLOR Biotech, Inc., a company developing next-generation biobetter therapeutic proteins, today announced the initiation of a pivotal Phase III clinical trial of hGH-CTP, the company's proprietary version of human growth hormone, in growth hormone deficient adults.

4 Jun 2013

Duke Medicine, UCSF investigators to oversee research program on antibacterial resistance

Investigators at Duke Medicine and the University of California, San Francisco have been selected to oversee a nationwide research program on antibacterial resistance, which includes a focus on the growing unmet challenges associated with methicillin-resistant Staphylococcus aureus and E. coli.

4 Jun 2013

Three health education leaders to be honored as 2013 Champions of Health Professions Diversity

Three inspiring leaders in health education will be honored by The California Wellness Foundation as the 2013 Champions of Health Professions Diversity for their successful efforts to improve the health and wellness of California's most underserved communities.

4 Jun 2013

Interval between pregnancies: A golden window for obese women to lose weight

The time between pregnancies is a golden window for obese women to lose weight, a Saint Louis University study finds.

4 Jun 2013

African-American women carry inherited genetic mutations that increase their risk for breast cancer

A high percentage of African-American women with breast cancer who were evaluated at a university cancer-risk clinic were found to carry inherited genetic mutations that increase their risk for breast cancer.

4 Jun 2013

Lupus Foundation of America announces Career Development Award and new summer fellowships

The Lupus Foundation of America, the only national force dedicated to solving the cruel mystery of lupus, announced recipients of five new summer fellowships and the Foundation's first-ever Career Development Award.

3 Jun 2013

Human tumors with MET amplification respond to MET inhibitor drugs

A subset of colorectal cancers responds to anti-epidermal growth factor receptor (anti-EGFR) therapies, but develops resistance within months. Among cancers that develop resistance to anti-EGFR therapy, some showed overexpression of a gene called MET, according to a study published in the June issue of Cancer Discovery, a journal of the American Association for Cancer Research.

3 Jun 2013

Study shows utility of cfDNA blood tests for breast cancer patients

Researchers from Chronix Biomedical and The University of Texas MD Anderson Cancer Center today announced that results from a pilot study demonstrating the utility of cell-free DNA (cfDNA) blood tests as a companion diagnostic for breast cancer patients are to be reported in a poster presentation titled "Modulation of breast cancer cell-free DNA with surgical resection" (Abstract #11060) at the American Society of Clinical Oncology Annual Meeting (ASCO 2013) being held from May 31 through June 4, 2013 in Chicago. The blood test detects cfDNA that is released into the blood stream by damaged and dying cancer cells.

1 Jun 2013

Alim Louis Benabid receives 2013 Robert A. Pritzker Prize for Leadership in Parkinson's Research

The Michael J. Fox Foundation for Parkinson's Research (MJFF) announced that Alim Louis Benabid , MD, PhD, is the recipient of the 2013 Robert A. Pritzker Prize for Leadership in Parkinson's Research.

1 Jun 2013

MannKind completes AFREZZA Phase 3 clinical study in patients with type 1 diabetes

MannKind Corporation today announced that all follow-up visits have been completed for the patients enrolled in Study 171, a Phase 3 clinical study of AFREZZA (insulin human [rDNA origin]) inhalation powder, an investigational, ultra rapid-acting mealtime insulin therapy, administered using MannKind's next-generation inhaler. MannKind expects to release data from this study later this summer.

1 Jun 2013

University of Strathclyde uses new imaging technique to track nanomedicines' effects on patients

A pioneering imaging technique to track the effects of next-generation nanomedicines on patients has been harnessed by a University of Strathclyde academic.

31 May 2013

Be ready for the next generation of cancer treatments

We cordially invite you to attend Markers in Cancer, a joint meeting by ASCO, EORTC & NCI which will be held 7 - 9 November 2013 in Brussels.

31 May 2013

PharmAthene announces lifting of clinical hold on proposed SparVax Phase II study

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the U.S. Food and Drug Administration has lifted the clinical hold previously placed on a proposed Phase II study of SparVax, a next generation recombinant anthrax vaccine.

31 May 2013

Next Generation News and Research

Cedars-Sinai Graduate Program to award diplomas to six students

Summa Akron City Hospital installs Toshiba's Aquilion ONE, Infinix-i systems

Data emphasise need for comprehensive analysis of mtDNA in mitochondrial disease patients

McGill researchers use computer simulations to show how immune cells identify foreign antigens

Researchers find new way to repair genetic defects in the skin cells of epidermolysis bullosa patients

CytomX collaborates with Pfizer to develop, commercialize more effective antibody-drug conjugates

WHO issues 24 Essential Nutrition Actions to prevent undernutrition and overweight

PROLOR Biotech announces initiation of hGH-CTP Phase III trial in growth hormone deficient adults

Duke Medicine, UCSF investigators to oversee research program on antibacterial resistance

Three health education leaders to be honored as 2013 Champions of Health Professions Diversity

Interval between pregnancies: A golden window for obese women to lose weight

African-American women carry inherited genetic mutations that increase their risk for breast cancer

Lupus Foundation of America announces Career Development Award and new summer fellowships

Human tumors with MET amplification respond to MET inhibitor drugs

Study shows utility of cfDNA blood tests for breast cancer patients

Alim Louis Benabid receives 2013 Robert A. Pritzker Prize for Leadership in Parkinson's Research

MannKind completes AFREZZA Phase 3 clinical study in patients with type 1 diabetes

University of Strathclyde uses new imaging technique to track nanomedicines' effects on patients

Be ready for the next generation of cancer treatments

PharmAthene announces lifting of clinical hold on proposed SparVax Phase II study

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News